Background Ventricular tachycardia with structural heart disease is dependent on re-entry within scar regions. We set out to assess the VT circuit in greater detail than has hitherto been possible, using ultra highdensity mapping. Methods All ultra high-density mapping guided ventricular tachycardia ablation cases from six high-volume European centres were assessed. Maps were analysed offline to generate activation maps of tachycardia circuits. Topography, conduction velocity and voltage of the VT circuit were analyzed in complete maps. Results Thirty-six tachycardias in 31 patients were identified, 29 male and 27 ischaemic. VT circuits and isthmuses were complex, eleven were single-loop and 25 double-loop; three had two entrances, five had two exits and 15 had dead ends of activation. Isthmuses were defined by barriers which included anatomical obstacles, lines of complete block and slow conduction (in 27/36 isthmuses). Median conduction velocity was 0.08m/s in entrance zones, 0.29m/s in isthmus regions (p<0.001), and 0.11m/s in exit regions (p=0.002). Median local voltage in the isthmus was 0.12mV during tachycardia and 0.06mV in paced/sinus rhythm. Two circuits were identifiable in five patients. The median timing of activation was 16% of diastole in entrances, 47% in the mid isthmus, and 77% in exits. Conclusions VT circuits identified were complex, some of them having multiple entrances, exits and dead ends. The barriers to conduction in the isthmus appear to be partly functional in 75% of circuits. 3 Conduction velocity in the VT isthmus slowed at isthmus entrances and exits, when compared with the mid isthmus. Isthmus voltage is often higher in VT than in sinus or paced rhythms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.